Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS Bank officially announced its IPO

4/12/24 MTSS

X5 Retail Group will revise its dividend policy

4/12/24 X5

Zaimer IPO was at the lower end of the price range

4/12/24 ZAYM

Board of Directors of Henderson recommended dividends

4/12/24 HNFG

Pharmsintez reported for 2023 by RAS

4/11/24 LIFE

TKZ Krasny Kotelshchik reported for 2023 by RAS

4/11/24 KRKO

Rusagro's operating company moves to Belgorod

4/11/24 RAGR

VK launched an open beta test of generative neural networks

4/11/24 VKCO

Board of Directors of RosDorBank recommended dividends

4/11/24 RDRB

Severstal restores electric steel production volume

4/11/24 CHMF